High-dose/activation-associated tolerance: A mechanism for allograft tolerance

Transplantation

Volumn 64, Issue 10, 1997, Pages 1377-1382

  Bishop, G Alex ^a,c   Sun, Junhong ^b   Sheil, A G Ross ^b   McCaughan, Geoffrey W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; REVIEW; T LYMPHOCYTE;

EID: 0030776194     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00001     Document Type: Review

References (72)

1. Talmage DW, Dart G, Radovich J, Lafferty KJ. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976; 191; 385.
2. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
3. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene expression in vascularized organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
4. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
5. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP. Peripheral tolerance of an allograft in adult rats: characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992; 54: 219.
6. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
7. Kamada N, Davies H, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981; 292: 840.
8. Sun J, McCaughan GW, Gallagher ND, Sheil AGR, Bishop GA. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60: 233.
9. Shimizu Y, Goto S, Lord R, et al. Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leukocytes. Transplant Int 1996; 9: 593.
10. Tu YZ, Arima T, Flye MW. Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 1997; 63: 177.
11. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993; 25: 3337.
12. Bishop GA, Sun J, DeCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
13. Sun J, Sheil AGR, Wang C, et al. Tolerance to rat liver allografts. IV. Tolerance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996; 62: 1725.
14. Mitchison NA. The dosage requirements for immunological paralysis by soluble proteins. Immunology 1968; 15: 509.
15. Sercarz E, Coons AH. Specific inhibition of antibody formation during immunological paralysis and unresponsiveness. Nature 1959; 184: 1080.
16. Brent DL, Gowland G. Induction of tolerance of skin homografts in immunologically competent mice. Nature 1962; 196; 1208.
17. McKhann CF. Weak histocompatibility genes: the effect of dose and pretreatment of immunizing cells. J Immunol 1962; 88: 500.
18. Skoskiewicz M, Chase C, Winn HJ, Russell PS. Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc 1973; 5: 721.
19. Qian S, Demetris A, Murase N, Rao A, Fung J, Starzl T. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
20. Kamada N, Shinomiya T. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 1985; 55: 85.
21. Ramos HC, Reyes J, Abuelmagd K, et al. Weaning of immuno-suppression in long-term liver transplant recipients. Transplantation 1995; 59: 212.
22. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369.
23. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
24. Hutchinson IV. Suppressor T cells in allogeneic models. Transplantation 1986; 41: 547.
25. Gassel HJ, Hutchinson IV, Engemann R, Morris PJ. The role of T suppressor cells in the maintenance of spontaneously accepted orthotopic rat liver allografts. Transplantation 1992; 54: 1048.
26. Kamada N, Brons G, Davies HS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29: 429.
27. Davies H, Pollard S, Calne R. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
28. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2: 1005.
29. Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990; 50: 678.
30. Priestley CA, Dalchau R, Sawyer GJ, Fabre JW. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation 1989; 48: 1031.
31. Qian S, Fu F, Li Y, et al. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology 1996; 88: 124.
32. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism and graft acceptance. Lancet 1992; 339: 1579.
33. Sriwatanawongsa V, Davies HS, Calne RY. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nature Med 1995; 1: 428.
34. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
35. Starzl TE, Demetris A, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
36. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993; 14: 326.
37. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nature Med 1996; 2:198.
38. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
39. Demetris AJ. Early events in liver allograft rejection. Am J Pathol 1991; 138: 609.
40. Hoffman LA, Codner MA, Shuster BA, et al. Donor leukocyte migration following extremity transplantation in an experimental model. Plast Reconstr Surg 1992; 90: 999.
41. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
42. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival. Transplantation 1997; 63: 7.
43. Lord R, Goto S, Kobayashi E, Kamada N, Sunagawa M. Detection of membrane-bound and soluble MHC class I antigen from donor migrating cells following rat liver transplantation. Transplant Immunol 1994; 2: 94.
44. Kobayashi E, Kamada N, Delriviere L, et al. Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat. Immunology 1995; 84: 333.
45. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
46. Kearney ER, Pape KA, Loh DY, Jenkins M. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994; 1: 327.
47. Rocha B, von-Boehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251: 1225.
48. Ucker DS, Hebshi LD, Blomquist JF, Torbett BE. Physiological T-cell death: susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant. Immunol Rev 1994; 142: 273.
49. Critchfield JM, Lenardo MJ. Antigen-induced programmed T cell death as a new approach to immune therapy. Clin Immunol Immunopathol 1995; 75: 13.
50. LaSalle JM, Hafler DA. T cell anergy. FASEB J 1994; 8: 601.
51. Thai NL, Li Y, Fu F, et al. Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transplant Surg 1997; 3: 118.
52. Sun J, McCaughan GW, Matsumoto Y, Sheil AGR, Gallagher ND, Bishop GA. Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994; 57: 1349.
53. Kaliss N. Immunological enhancement of tumor homografts in mice. Cancer Res 1958; 18: 992.
54. Shirwan H, Cosenza C, Wang HK, Wu G-D, Makowka L, Cramer DV. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Transplantation 1994; 57: 1072.
55. Egawa H, Martinez OM, Quinn MB, et al. Acute liver allograft rejection in the rat: an analysis of the immune response. Transplantation 1995; 59: 97.
56. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993; 362: 758.
57. von-Boehmer H. Immunology: tolerance by exhaustion. Nature 1993; 362: 696.
58. Critchfield J, Racke M, Zuniga-Pflucker J, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139.
59. McKenzie JL, Beard ME, Hart DN. The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation 1984; 38: 371.
60. Stuart FP, Garrick T, Holter A, Lynch A, Bastien E. Delayed rejection of renal allografts in the rat and dog by reduction of passenger leukocytes. Surgery 1971; 70: 128.
61. Prop J, Niewenhuis P, Wildevuur CRH. Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes. Transplantation 1985; 40: 25.
62. Sun J, Bishop GA, Wang C, Wang L, McCaughan G, Sheil R. Quantity of donor tissue and rat allograft survival. Transplant Proc 1997; 29: 1143.
63. Medawar PB. The behaviour and fate of skin autografts and skin homografts in rabbits. J Anat 1944; 78: 176.
64. Cranston D, Wood KJ, Morris PJ. Abrogation of the immunosuppressive effect of donor spleen cells on renal allografts in the rat by irradiation or heat treatment. Transplantation 1986; 42: 302.
65. Marquet RL, Heystek GA, Tinbergen WJ. Specific inhibition of organ allograft rejection by donor blood. Transplant Proc 1971; 3: 708.
66. Stuart FP, Saitoh T, Fitch FW. Rejection of renal allografts: specific immunologic suppression. Science 1968; 160: 1463.
67. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
68. Thomson AW, Lu L, Subbotin VM, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 1995; 59: 544.
69. Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995; 182: 379.
70. Lu L, Bonham CA, Chambers FG, et al. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin and interaction with allogeneic T cells. J Immunol 1996; 157: 3577.
71. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. Granulocyte macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
72. Steptoe RJ, Fu F, Li W, et al. Donor pretreatment with flt3 ligand augments liver and heart dendritic cell number and exacerbates allograft rejection. J Allergy Clin Immunol 1997; 99: S483.